Mesa Laboratories, Inc. · NASDAQ:MLAB
Mesa Laboratories — Investor Presentation (February 2012)
25 slides from Mesa Laboratories's investor presentation, Feb 21, 2012

Slide 1: Mesa Laboratories, Inc. "MLAB"
Mesa Laboratories, Inc. “MLAB” John Sullivan, President and CEO Steve Peterson, VP Finance and CFO

Slide 2: Safe Harbor Statement
Safe Harbor Statement Certain statements in this communication may be “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding future prospects and developments a

Slide 3: Mesa Labs Performance Summary
Mesa Labs Performance Summary History of Highly Profitable Operations 60% - 65% Gross Margins 30% - 35% Operating Income 20% - 25% Net Income Highly Effective Growth Strategy 21% 5-Yr. Revenue CAGR 18% 5-Yr Net Income CAGR

Slide 4: Mesa Labs "MLAB" on the NASDAQ
Mesa Labs “MLAB” on the NASDAQ Founded in 1982, IPO in 1984 Manufacturer of Electronic Instruments and Disposable Products for Specialty Markets Offices in Colorado, Nebraska, Montana ~180 Employees Two Divisions Instruments Biological Indicators

Slide 5: Mesa Labs Today
Mesa Labs Today Lakewood, CO Medical, DataTrace, Nusonics, Torqo Omaha, NE - Biological Indicators Bozeman, MT - Biological Indicators

Slide 6: Mesa's Products
Mesa’s Products Focus on Products for Quality Control Regulated Industries and Applications High Value, High Technology Limited Competition Niche Markets and Applications

Slide 7: Mesa's Markets
Mesa’s Markets Instruments Quality Control Dialysis Clinics Food and Beverage Pharma MFG Medical Device MFG Biological Indicators Sterility Quality Control Dental Offices Hospitals Pharma MFG Medical Device MFG Biotechnology

Slide 8: Medical Products
Medical Products Hemodialysis Meters for Machine Calibration Calibration Standards Hemodialysis Meters for Daily Clinic Quality Control

Slide 9: DataTrace Data Loggers
DataTrace Data Loggers Micropack-III System Micropack-RF System

Slide 10: Torqo Products
Torqo Products Torqo II Cap Torque Testing Instrument Gold Bottle Torque Testing Data Logger

Slide 11: Biological Indicators
Biological Indicators

Slide 12: Financial Information
= > m wo a w > Financial Information

Slide 13: Q3, FY'12 Summary
Q3, FY’12 Summary 2011 2010 Change Revenues $9,259 $7,652 21% Gross profit 5,885 4,440 GM % 64% 58% Operating income 3,162 2,002 Op Inc % 34% 26% Net income $1,987 $1,258 58% Net Inc % 21% 16% EPS (diluted) $0.57 $0.37 (Dollars in $000, except EPS)

Slide 14: 5-Year Sales History
5-Year Sales History (TTM 12/31/11) 21% CAGR 12,000 16,000 20,000 24,000 28,000 32,000 36,000 Dec'06 Dec'07 Dec'08 Dec'09 Dec'10 Dec'11 12-Month Sales - $000

Slide 15: Net Income History
Net Income History FYE – March 31 TTM, 12/31/11 $- $1,000 $2,000 $3,000 $4,000 $5,000 $6,000 $7,000 $8,000 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Net Income ($000)

Slide 16: Earnings and Dividend
Earnings and Dividend FYE – March 31 TTM, 12/31/11 $- $0.50 $1.00 $1.50 $2.00 $2.50 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Regular Dividend Special Dividend Earnings per Share

Slide 17: Historical Performance
Historical Performance FYE – March 31 23% 35% 63% 2003 23% 36% 62% 2004 23% 35% 63% 2005 24% 35% 64% 2006 23% 33% 63% 2007 21% 19% 22% 22% 24% Net Income 33% 30% 34% 35% 36% Operating Inc. 62% 60% 60% 64% 66% Gross Profit 9 mo 2012 2011 2010 2009 2008

Slide 18: MLAB Share Price
MLAB Share Price 10 Years $10 $15 $20 $25 $30 $35 $40 $45 $50

Slide 19: Going Forward
= > m Cy wa a > Going Forward

Slide 20: Primary Strategic Goals
Primary Strategic Goals Revenue Growth near Mesa’s Recent Historic Rate Maintain Profit Margins at, or Near, Long-Term Averages Continue our Focus on Maximizing Shareholder Value

Slide 21: Organic Growth Strategy
Organic Growth Strategy Focus on Growing Markets Improved Distribution Channels Increase direct sales Improved distributor base Focus on E-marketing New Products Increased R&D funding

Slide 22: Acquisition Growth Strategy
Acquisition Growth Strategy Market Selection Niche, Regulation Driven, Growing Products High Technology, High Value, High Margin Competition Few Competitors, Strong Mesa Position Mesa Will Continue to Pursue Strategic Acquisitions (~Half of Mesa’s 5-Year growth is due to acquisitions)

Slide 23: Mesa's Significant Acquisitions
Mesa’s Significant Acquisitions Apex Disc, 2010: Biological Indicators for Hydrogen Peroxide SGM Biotech, 2010: Biological Indicators for Sterilization Quality Control Torqo, 2009: Bottle Cap Torque Testing Instruments Raven, 2006: Biological Indicators for Sterilization Quality Control Automata, 19

Slide 24: Mesa Labs Summary
Mesa Labs Summary Highly Profitability Consistent Revenue and Income Growth Conservative, “Shareholder Focused” Management “Dividend Paying Growth Company”

Slide 25: Thank You!
Thank You! John Sullivan jsullivan@mesalabs.com Steve Peterson steve@mesalabs.com NASDAQ: MLAB Phone 303-987-8000
Source: SEC EDGAR · 8-K filed Feb 21, 2012
More decks from Mesa Laboratories, Inc.
Q2 2027 Earnings Presentation8 slides · Nov 9, 2026
FY2026 Earnings Presentation20 slides · May 27, 2026
Merger or Acquisition (September 2021)9 slides · Sep 14, 2021
Investor Presentation (June 2020)19 slides · Jun 1, 2020
Investor Presentation (December 2019)26 slides · Dec 2, 2019
Merger or Acquisition (November 2019)7 slides · Nov 4, 2019